# A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

> **NCT07300969** · PHASE2 · RECRUITING · sponsor: **Draig Therapeutics Ltd** · enrollment: 300 (estimated)

## Conditions studied

- Major Depressive Disorder (MDD)

## Interventions

- **DRUG:** DT-101
- **DRUG:** DT-101
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07300969
- **Lead sponsor:** Draig Therapeutics Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-16
- **Primary completion:** 2027-08
- **Final completion:** 2027-08
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07300969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07300969, "A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07300969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*